RVTY Stock Summary and Trading Ideas (Revvity | NYSE:RVTY)

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

Revvity trades on the NYSE stock market under the symbol RVTY.

As of January 16, 2026, RVTY stock price declined to $112.50 with 1,460,266 million shares trading.

RVTY has a beta of 0.95, meaning it tends to be less sensitive to market movements. RVTY has a correlation of 0.19 to the broad based SPY ETF.

RVTY has a market cap of $12.75 billion. This is considered a Large Cap stock.

Last quarter Revvity reported $699 million in Revenue and $1.18 earnings per share. This fell short of revenue expectation by $-787,052 and exceeded earnings estimates by $.04.

The top ETF exchange traded funds that RVTY belongs to (by Net Assets): VTI, VOO, VB, RSP, IVV.

RVTY has underperformed the market in the last year with a return of -5.5%, while SPY returned +18.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in RVTY shares. However, RVTY has outperformed the market in the last 3 month and 2 week periods, returning +19.9% and +14.7%, while SPY returned +5.0% and +1.2%, respectively. This indicates RVTY has been having a stronger performance recently.

RVTY support price is $112.63 and resistance is $117.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RVTY shares will trade within this expected range on the day.